The importance of accounting for the uncertainty around the preference-based health-related quality-of-life measures value sets: a systematic review

被引:0
作者
Kharroubi, Samer A. [1 ]
Beyh, Yara [1 ]
机构
[1] Amer Univ Beirut, Fac Agr & Food Sci, Beirut, Lebanon
关键词
Uncertainty; preference-based health measure; SF-6D; EQ-5D; health-related quality-of-life; Bayesian methods; COST-EFFECTIVENESS ANALYSIS; DECISION-ANALYTIC MODELS; TIME TRADE-OFF; ECONOMIC-EVALUATION; STRUCTURAL UNCERTAINTY; PARAMETER UNCERTAINTY; QUANTIFYING PARAMETER; PATIENT HETEROGENEITY; UTILITY; EQ-5D;
D O I
10.1080/13696998.2019.1592178
中图分类号
F [经济];
学科分类号
02 ;
摘要
Preference-based measures of health-related quality-of-life including, but not limited to, the EQ-5D, HUI2 and the SF-6D have been increasingly used in calculations of quality-adjusted life years for cost effectiveness analyses. However, the uncertainty around the measures' value sets is commonly ignored in economic evaluation. There are several types of uncertainties, including methodological, structural, and parameter uncertainties, with the latter being the focus of this review paper. The objective is to highlight the gap in the literature regarding the existence of uncertainty in the value sets, focusing mainly on the EQ-5D and SF-6D. To the best of the authors' knowledge, this is the first systematic review revolving around uncertainty. After searching extensively for studies involving uncertainties in all preference-based measures, the results showed that uncertainty has been approached through different means, while parameter uncertainty has been ignored in most, if not all, cases. These findings suggest that uncertainty should be accounted for when using preference-based measures in economic evaluations. Ignoring this additional information could impact misleadingly on policy decisions.
引用
收藏
页码:671 / 683
页数:13
相关论文
共 81 条
[1]  
[Anonymous], 1995, BAYESIAN DATA ANAL, DOI DOI 10.1201/9780429258411
[2]  
[Anonymous], 1948, PREAMBL CONST WHO AD
[3]  
[Anonymous], 1988, METHODS EC EVALUATIO
[4]  
[Anonymous], 2004, PHARM STAT, DOI DOI 10.1002/PST.130
[5]  
Ara R, 2011, 12 U SHEFF SCH HLTH
[6]   Populating an Economic Model with Health State Utility Values: Moving toward Better Practice [J].
Ara, Roberta ;
Brazier, John E. .
VALUE IN HEALTH, 2010, 13 (05) :509-518
[7]  
Augustovski F, 2016, QUAL LIFE RES, V25, P323, DOI 10.1007/s11136-015-1086-4
[8]   A predictive Bayesian approach to risk analysis in health care [J].
Aven, Terje ;
Eidesen, Karianne .
BMC MEDICAL RESEARCH METHODOLOGY, 2007, 7 (1)
[9]   Economic Evaluation of Cinacalcet in the United States: The EVOLVE Trial [J].
Belozeroff, Vasily ;
Chertow, Glenn M. ;
Graham, Christopher N. ;
Dehmel, Bastian ;
Parfrey, Patrick S. ;
Briggs, Andrew H. .
VALUE IN HEALTH, 2015, 18 (08) :1079-1087
[10]   Quantifying Parameter and Structural Uncertainty of Dynamic Disease Transmission Models Using MCMC: An Application to Rotavirus Vaccination in England and Wales [J].
Bilcke, Joke ;
Chapman, Ruth ;
Atchison, Christina ;
Cromer, Deborah ;
Johnson, Helen ;
Willem, Lander ;
Cox, Martin ;
Edmunds, William John ;
Jit, Mark .
MEDICAL DECISION MAKING, 2015, 35 (05) :633-647